Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area

Metabolism: Clinical and Experimental

Volumn 62, Issue 7, 2013, Pages 970-975

  Anil, Cuneyd ^a   Akkurt, Aysen ^a   Ayturk, Semra ^a   Kut, Altug ^a   Gursoy, Alptekin ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Diabetes mellitus; Impaired fasting glucose; Impaired glucose tolerance; Thyroid nodule; Volume

Indexed keywords

THYROID ANTIBODY; THYROTROPIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE METABOLISM; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING HABIT; THYROID FUNCTION; THYROID NODULE; THYROTROPIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

AUTOANTIBODIES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GOITER, ENDEMIC; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; INSULIN RESISTANCE; IODINE; MALE; MIDDLE AGED; ORGAN SIZE; PREDIABETIC STATE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; THYROID GLAND; THYROID NODULE; THYROTROPIN; TURKEY;

EID: 84879551711     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.01.009     Document Type: Article

References (26)

1. H. Gharib, and E. Papini Thyroid nodules: clinical importance, assessment, and treatment Endocrinol Metab Clin North Am 36 2007 707 735
2. S. Ayturk, A. Gursoy, and A. Kut Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area Eur J Endocrinol 161 2009 599 605
3. J. Rezzonico, M. Rezzonico, and E. Pusiol Introducing the thyroid gland as another victim of the insulin resistance syndrome Thyroid 18 2008 461 464
4. R. Junik, M. Kozinski, and K. Debska-Kozinska Thyroid ultrasound in diabetic patients without overt thyroid disease Acta Radiol 47 2006 687 691
5. W.P. Pimenta, G.M. Mazeto, and C.F. Callegaro Thyroid disorders in diabetic patients Arq Bras Endocrinol Metabol 49 2005 234 240
6. C. Cappelli, M. Rotondi, and I. Pirola Thyreotropin levels in diabetic patients on metformin treatment Eur J Endocrinol 167 2 2012 261 265 [Epub 2012]
7. J. Rezzónico, M. Rezzónico, and E. Pusiol Metformin treatment for small benign thyroid nodules in patients with insulin resistance Metab Syndr Relat Disord 9 1 2011 69 75
8. C.M. Rhee, I. Bhan, and E.K. Alexander Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism Arch Intern Med 172 2 2012 153 159
9. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 1 Suppl 1 2008 S55 S60
10. G. Erdoǧan, M.F. Erdogan, and R. Emral Iodine status and goiter prevalence in Turkey before mandatory iodization J Endocrinol Invest 25 2002 224 228
11. M.F. Erdoǧan, O. Demir, and R. Emral More than a decade of iodine prophylaxis is needed to eradicate goiter among school age children in a moderately iodine-deficient region Thyroid 19 2009 265 268
12. M. Rosenbaum, J. Hirsch, and E. Murphy Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function Am J Clin Nutr 71 2000 1421 1432
13. T. Zimmermann-Belsing, G. Brabant, and J.J. Holst Circulating leptin and thyroid dysfunction Eur J Endocrinol 149 2003 257 271
14. M.I. Schmidt, B.B. Duncan, A. Vigo ARIC Investigators Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49 2006 2086 2096
15. K. Lewandowski, H.S. Randeva, and C.J. O'Callaghan Effects of insulin and glucocorticoids on the leptin system are mediated through free leptin Clin Endocrinol 54 2001 533 539
16. C. Menendez, R. Baldelli, and J.P. Camiña TSH stimulates leptin secretion by a direct effect on adipocytes J Endocrinol 176 2003 7 12
17. B. Rapoport, G.D. Chazenbalk, and J.C. Jaume The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies Endocr Rev 19 1998 673 716
18. T. Kimura, A. Van Keymeulen, and J. Golstein Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models Endocr Rev 22 2001 631 656
19. J. Riedemann, and V.M. Macaulay IGF1R signalling and its inhibition Endocr Relat Cancer 13 Suppl 1 2006 S33 S43
20. S. Mohan, D.J. Baylink, and J.L. Pettis Insulin-like growth factor (IGF)-binding proteins in serum-do they have additional roles besides modulating the endocrine IGF actions? J Clin Endocrinol Metab 81 1996 3817 3820
21. P. Santisteban, A. Acebrón, and M. Polycarpou-Schwarz Insulin and insulin-like growth factor I regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter Mol Endocrinol 6 1992 1310 1317
22. R. Malaguarnera, F. Frasca, and A. Garozzo Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid J Clin Endocrinol Metab 96 2011 766 774
23. N. Mitsiades, K. Pazaitou-Panayiotou, and K.N. Aronis Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies J Clin Endocrinol Metab 96 12 2011 E2023 E2028
24. D. Barb, C.J. Williams, and A.K. Neuwirth Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence Am J Clin Nutr 86 2007 s858 s866
25. A. Kokkinos, I. Mourouzis, and D. Kyriaki Possible implications of leptin, adiponectin and ghrelin in the regulation of energy homeostasis by thyroid hormone Endocrine 32 1 2007 30 32
26. S.Y. Lin, S.C. Huang, and W.H. Sheu Circulating adiponectin concentrations were related to free thyroxine levels in thyroid cancer patients after thyroid hormone withdrawal Metabolism 59 2 2010 195 199